| Period Ending | Feb 1, 2013 | Oct 26, 2012 | Jul 27, 2012 | Apr 27, 2012 |
|---|
|
Total Revenue
|
190,508
|
228,434
|
210,305
|
173,824
| | Cost of Revenue | 149,140 | 167,607 | 152,505 | 132,839 | | |
Gross Profit
|
41,368
|
60,827
|
57,800
|
40,985
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 54,144 | 62,081 | 63,509 | 59,265 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(12,776)
|
(1,254)
|
(5,709)
|
(18,280)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,330 | 2,313 | (11,673) | 3,024 |
|
Earnings Before Interest And Taxes | (6,446) | 1,059 | (17,382) | (15,256) |
|
Interest Expense | 13,345 |
-
|
-
|
-
|
|
Income Before Tax | (19,791) | 1,059 | (17,382) | (15,256) |
|
Income Tax Expense | 214 | 111 | 156 | 367 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (20,005) | 948 | (17,538) | (15,623) | |
|
Non-recurring Events |
|
Discontinued Operations | 144 |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(19,861)
|
948
|
(17,538)
|
(15,623)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(19,861)
|
948
|
(17,538)
|
(15,623)
|
|
0.01(0.34%) 2:12PM EDT - Nasdaq Real Time Price